SynthesisFrontiers in oncology2020

Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis.

Ya-Fang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.